GGrantIndex
← Search

HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C

$250,448P50FY2013CANIH

Sloan-Kettering Inst Can Research, New York NY

Investigators

Linked publications & trials

View original record on NIH RePORTER →